Reviewing U.S. Physical Therapy (USPH) & The Competition
U.S. Physical Therapy (NYSE: USPH) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its rivals? We will compare U.S. Physical Therapy to related companies based on the strength of its analyst recommendations, dividends, earnings, valuation, risk, profitability and institutional ownership.
Earnings & Valuation
This table compares U.S. Physical Therapy and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|U.S. Physical Therapy||$356.55 million||$20.55 million||42.56|
|U.S. Physical Therapy Competitors||$1.06 billion||-$22.56 million||738.50|
Volatility and Risk
U.S. Physical Therapy has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, U.S. Physical Therapy’s rivals have a beta of 1.47, indicating that their average stock price is 47% more volatile than the S&P 500.
Insider and Institutional Ownership
99.8% of U.S. Physical Therapy shares are owned by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 3.1% of U.S. Physical Therapy shares are owned by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This table compares U.S. Physical Therapy and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|U.S. Physical Therapy||5.29%||13.37%||6.63%|
|U.S. Physical Therapy Competitors||3.52%||3.52%||4.31%|
U.S. Physical Therapy pays an annual dividend of $0.80 per share and has a dividend yield of 1.1%. U.S. Physical Therapy pays out 48.2% of its earnings in the form of a dividend. As a group, “Hospitals, Clinics & Primary Care Services” companies pay a dividend yield of 1.0% and pay out 37.9% of their earnings in the form of a dividend. U.S. Physical Therapy has increased its dividend for 6 consecutive years.
This is a summary of current recommendations and price targets for U.S. Physical Therapy and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|U.S. Physical Therapy||0||2||2||0||2.50|
|U.S. Physical Therapy Competitors||57||326||509||9||2.52|
U.S. Physical Therapy presently has a consensus price target of $70.25, indicating a potential downside of 0.57%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 24.81%. Given U.S. Physical Therapy’s rivals stronger consensus rating and higher possible upside, analysts clearly believe U.S. Physical Therapy has less favorable growth aspects than its rivals.
U.S. Physical Therapy rivals beat U.S. Physical Therapy on 9 of the 15 factors compared.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company’s segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates 562 physical therapy clinics in 42 states. There are approximately 380 clinics operated under Clinic Partnerships and over 100 operated as Company-owned Facilities. In addition to its owned clinics, it also manages physical therapy facilities for third parties, primarily physicians, with over 29 third-party facilities under management.
Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.